References
- Ritz MC, George FR. Cocaine toxicity: concurrent influence of dopaminergic, muscarinic and sigma receptors in mediating cocaine-induced lethality. Psychopharmacology (Berl) 1997; 129:311–321.
- Ritz MC, George FR. Cocaine-induced convulsions: pharmacological antagonism at serotonergic, muscarinic and sigma receptors. Psychopharmacology (Berl) 1997; 129:299–310.
- Ritz MC, George FR. Cocaine-induced seizures and lethality appear to be associated with distinct central nervous system binding sites. J Pharmacol Exp Ther 1993; 264:1333–1343.
- Derlet RW, Albertson TE. Diazepam in the prevention of seizures and death in cocaine-intoxicated rats. Ann Emerg Med 1989; 18:542–546.
- Schmidt AW, Lebel LA, Howard HRJr, Zorn SH. Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile. Eur J Pharmacol 2001; 425:197–201.
- Visalli T, Turkall R, Abdel-Rahman MS. Gender differences in cocaine pharmacokinetics in CF-1 mice. Toxicol Lett 2005; 155:35–40.
- Acute Oral Toxicity (AOT). Up-And-Down-Procedure: United States Environmental Protection Agency. http://www.epa.gov/oppfead1/harmonization/. Accessed 11 August 2008.
- Cleveland NR, Krier S, Heard K. Ziprasidone, diazepam, or the combination for prevention of cocaine toxicity in a mouse model. Acad Emerg Med 2007; 14:691–694.
- Derlet RW, Albertson TE, Rice P. The effect of haloperidol in cocaine and amphetamine intoxication. J Emerg Med 1989; 7:633–637.
- Derlet RW, Albertson TE, Rice P. Antagonism of cocaine, amphetamine, and methamphetamine toxicity. Pharmacol Biochem Behav 1990; 36:745–749.
- Schotte A, Janssen PF, Gommeren W, Luyten WH, Van Gompel P, Lesage AS, De Loore K, Leysen JE. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology (Berl) 1996; 124:57–73.
- Wood DM, Dargan PI, Hoffman RS. Management of cocaine-induced cardiac arrhythmias due to cardiac ion channel dysfunction. Clin Toxicol (Phila) 2008; 46:1–10.
- Knuepfer MM. Cardiovascular disorders associated with cocaine use: myths and truths. Pharmacol Ther 2003; 97:181–222.
- Bymaster FP, Calligaro DO, Falcone JF, Marsh RD, Moore NA, Tye NC, Seeman P, Wong DT. Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology 1996; 14:87–96.
- Dose Calculator: United States Food and Drug Administration. http://www. accessdata.fda.gov/scripts/cder/onctools/animalresults.cfm. Accessed 11 August 2008.